Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine.
about
Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence.Factors associated with school nurses' HPV vaccine attitudes for school-aged youth.Human Papillomavirus Vaccine Sources of Information and Adolescents' Knowledge and Perceptions.Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.9-Valent human papillomavirus vaccine: a review of the clinical development program.Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.
P2860
Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase III, randomized controll ...... 1 virus-like particle vaccine.
@ast
Phase III, randomized controll ...... 1 virus-like particle vaccine.
@en
type
label
Phase III, randomized controll ...... 1 virus-like particle vaccine.
@ast
Phase III, randomized controll ...... 1 virus-like particle vaccine.
@en
prefLabel
Phase III, randomized controll ...... 1 virus-like particle vaccine.
@ast
Phase III, randomized controll ...... 1 virus-like particle vaccine.
@en
P2093
P2860
P1476
Phase III, randomized controll ...... L1 virus-like particle vaccine
@en
P2093
Alain Luxembourg
Erin Moeller
Joshua Chen
Kyung-Hyo Kim
Roger Maansson
Rudiwilai Samakoses
Susan Christiano
P2860
P304
P356
10.1080/21645515.2015.1009819
P577
2015-01-01T00:00:00Z